Geometry Dash APK Hill Climb Racing APK
15.6 F
New York
Friday, January 21, 2022

Inovio Pharmaceuticals Inc (NASDAQ:INO) Scores on Mad Money

Must read

Bombardier, Inc. (OTCMKTS:BDRBF) Continues to Gain Momentum and Strength

Many stocks have managed to record significant gains in recent months and one that often flies under the radar is Bombardier,...

Grayscale Bitcoin Trust (Btc) (GBTC) Makes Big Move As Bitcoin Goes Wild

Bitcoin, the world’s biggest cryptocurrency by market cap, has been in the middle of a remarkable rally for the past few months...

Voyager Digital Ltd (OTCMKTS:VYGVF) Hits All-Time High on Download News

The remarkable rally enjoyed by several crypto assets over the course of the past months has also resulted in an increased demand...

Solar Integrated Roofing Corp (OTCMKTS:SIRC) Surges Higher On Sector Strength

The Solar Integrated Roofing Corp (OTCMKTS:SIRC) stock has come into sharp focus among investors and on Wednesday, the stock made significant gains...

The coronavirus pandemic has had a profoundly negative effect on the stock market, and over the past few weeks, hundreds of stocks have recorded alarming declines.

What to Expect Now?

However, a handful of companies working on products meant to tackle the coronavirus, have seen their stocks record gains. One such stock is that of Inovio Pharmaceuticals Inc (NASDAQ:INO), which gained as much as 18% on Wednesday after it got positive coverage in the Mad Money show. Inovio is in the process of developing a coronavirus vaccine, and that has been the main reason behind the optimism around its stock in recent weeks.

That being said, it should be noted that the company is going to release data from its study later on in the summer, and hence, it seems that the Inovio stock soared primarily because of the coverage on Mad Money. In this regard, it is also necessary to point out that other companies are also working on coronavirus vaccines, and companies like Moderna are already ahead of Inovio in this regard. As a matter of fact, Inovio has been able to produce the vaccine ahead of storied pharmaceutical behemoths like Johnson & Johnson. Moderna has done the same, and on Wednesday, its stock recorded gains of 4%.

Inovio Pharmaceuticals is valued at $1.7 billion at this point, and if the company can manage to show progress in its vaccine development, then it could prove to be a stock worth considering. While a new vaccine can result in a significant rally in the stock, it is also necessary to keep in mind that there are certain associated risks that cannot be ignored.

There is currently no guarantee of whether the company is going to be able to come up with the product, and even if Inovio is successful, it is difficult to estimate the size of the coronavirus vaccine market. Last but not least, there is the small matter of competition from other companies as well.

Latest article

iQSTEL Inc (OTCMKTS:IQST) Stock Makes a Big Move: Jumps 45% In a Week

In the past week, iQSTEL Inc (OTCMKTS: IQST) has emerged as a point of focus among a large number of investors and...

HUMBL Inc (OTCMKTS:HMBL) Stock Sees Big Bounce After Recent Slump

Since the beginning of 2021, HUMBL Inc (OTCMKTS:HMBL) had been one of the major movers from among penny stocks and had come into...

Dividend Stocks to Buy Now

A classic mistake that investors make when looking for dividend stocks is to just go for the biggest dividend yield. It makes...

88 Energy Ltd (OTCMKTS:EEENF) Stock Surges 40% But Can’t Hold Gains

The oil and gas company 88 Energy Ltd (OTCMKTS:EEENF) seems to have come back on to the radars of investors over the...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service